← Leaderboards
Catherine Meyerle
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Liquid Substance”
- David Heimbrook · Leidos Biomedical Research, Inc.$198,808,018
- Randall J Bateman · Washington University$103,696,639
- Elizabeth A Thom · George Washington University$53,783,395
- Steven M Greenberg · Massachusetts General Hospital$45,690,069
- Thomas Gary Ksiazek · University Of Texas Med Br Galveston$32,195,929
- Natalia S Rost · Massachusetts General Hospital$31,323,044
Research focus
Liquid SubstanceParticipantPharmaceutical PreparationsSafetyExudative Age-Related Macular DegenerationRetinalEnrollmentDesignSerousBlindnessInjection Of Therapeutic AgentStructure Of Retinal Pigment EpitheliumRetinaChoroidal NeovascularizationComplexVisionAngiogenesis InhibitorsAbsorptionAndrogensAge Related Macular DegenerationExtravasationElderlyBevacizumabDose
Grant awards (8)
Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy$99,285
ZIA · FY2013 · EY · contact PI
High Speed ICG Ranibizumab AMD$99,285
ZIA · FY2013 · EY · contact PI
Phase 1 Palomid 529 TORC Neovascular AMD$54,370
ZIA · FY2013 · EY · contact PI
Central Serous Chorioretinopathy Topical Interferon Gamma-1b Jak Stat$30,731
ZIA · FY2013 · EY · contact PI
High Speed ICG Ranibizumab AMD$104,709
ZIA · FY2012 · EY · contact PI
Phase 1 Palomid 529 TORC Neovascular AMD$102,274
ZIA · FY2012 · EY · contact PI
Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy$102,274
ZIA · FY2012 · EY · contact PI
Central Serous Chorioretinopathy Topical Interferon Gamma-1b Jak Stat$77,923
ZIA · FY2012 · EY · contact PI